Dr. Domenico Veneziano

Dr. Domenico Veneziano
Domenico Veneziano MD, PhD is a Urologist at the Smith Institute of Urology, Northwell Health in New York. He is Director of Urology at Valley Stream LIJ hospital where he is in charge of the Urology robotic programme, he is Assistant Clinical Professor of Urology at the Hofstra-Northwell University of New York (USA). He performs a wide array of surgical techniques, including laparoscopic and robotic surgery for urological cancers, and minimally invasive surgery for prostate enlargement and urinary stones. He completed his medical studies in Italy in 2005, where he also completed his residency in 2011. He performed his laparoscopic training at the Universitätsklinikum Halle, Germany and in 2012 he achieved the European Board Certification in Urology (FEBU). “I always had an incredible passion for new technologies, my father is a urologist as well, which inspired in me the need to build my first laparoscopic training system when I was a student. Since then I never stopped practicing and teaching minimally invasive surgical techniques”. In 2014 he completed a fellowship at the University of Minnesota (USA) in “simulation and education technologies” with the accreditation of the American College of Surgeons, the first fellowship in the world exclusively dedicated to simulation in surgery. In 2019 he achieved a PhD in Simulation technologies at the Universidade do Minho in Braga, Portugal. In the same year he was awarded for the best under 40 Italian scientific curriculum by the Italian Society of Urology. Dr Veneziano is an internationally renowned key-opinion leader and pioneer in the field of surgical education and digital healthcare, with several novelties introduced in curriculum building, simulator design and in the organization of hands-on training events, with over 75 invited lectures since 2014 and over 80 courses directed in 16 different countries. Between them, several training events in Asia and the first-ever standardized hands-on training surgical course in USA, with the endorsement of the American Urological Association. Domenico Veneziano is author of some of the most impactful scientific papers and book chapters in the field of surgical education and project-coordinator of the EST-s1 and EST-s2 curriculums, actually delivered as a training/assessment tools for surgeons in 38 countries. In 2014-2018 he was Director of Hands on Training for the European Urological Residents Education Programme (EUREP), flagship educational programme of the European School of Urology, and is in charge of the development of novel training curriculums on behalf of the European Association of Urology (EAU). He is head of technical training / board member of the European School of Urology and holds 2 patents for surgical education technologies. Dr. Veneziano was editor of 2 books, published in 2022, about the latest surgical technologies and their applications in Urology. According to him, “Technology today helps to not only provide tailored solutions to our patients, but also to easily explain how we can solve their problems”.

Languages Spoken:

Italian, English

Medical School:

Università degli Studi di Messina (IT)

Residency:

Università Magna Graecia di Catanzaro (IT)

Fellowship:

University of Minnesota

All surgical treatments have inherent and associated side effects. Individual’s outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon experience. The most common side effects are mild and transient and may include mild pain or difficulty when urinating, discomfort in the pelvis, blood in the urine, inability to empty the bladder or a frequent and/or urgent need to urinate, and bladder or urinary tract infection. Other risks include ejaculatory dysfunction and a low risk of injury to the urethra or rectum where the devices gain access to the body for treatment. Further, there may be other risks as in other urological surgery, such as anesthesia risk or the risk of infection, including the potential transmission of blood borne pathogens. For more information about potential side effects and risks associated with Aquablation therapy for Benign Prostatic Hyperplasia (BPH) treatment, speak with your urologist or surgeon. Prior to using our products, please review the Instructions for Use, Operator’s Manual or User Manual, as applicable, and any accompanying documentation for a complete listing of indications, contraindications, warnings, precautions and potential adverse events. No claim is made that the AquaBeam Robotic System will cure any medical condition, or entirely eliminate the diseased entity. Repeated treatment or alternative therapies may sometimes be required.

Rx Only